For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Bostongene Corporation

USPTO Granted Patents = 34

EPO Patents = 10

Trademarks = 4

Forward Citations = 133

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Alexander Bagaev (30 out of 30 patents)

Ravshan Ataullakhanov (24 out of 27 patents)

Feliks Frenkel (21 out of 21 patents)

4. Nikita Kotlov (15 out of 15 patents)

5. Olga Isaeva (6 out of 6 patents)

6. Viktor Svekolkin (4 out of 4 patents)

7. Aleksandr Zaitsev (3 out of 3 patents)

8. Maksim Chelushkin (3 out of 3 patents)

9. Ekaterina Nuzhdina (3 out of 3 patents)

10. Ekaterina Postovalova (3 out of 3 patents)

11. Maksym Artomov (3 out of 3 patents)

12. Ilya Cheremushkin (2 out of 2 patents)

13. Vladimir Zyrin (2 out of 2 patents)

14. Daniiar Dyikanov (2 out of 2 patents)

15. Boris Shpak (2 out of 2 patents)

34 patents: Sort by Forward Citations

1. 12462941 - Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration (2025-11-04),

2. 12254961 - Hierarchical machine learning techniques for identifying molecular categories from expression data (2025-03-18),

3. 12205675 - Techniques for bias correction in sequence data (2025-01-21),

4. 11984200 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2024-05-14),

5. 11915422 - Techniques for determining tissue characteristics using multiplexed immunofluorescence imaging (2024-02-27),

6. 11904002 - Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines (2024-02-20),

7. 11842797 - Systems and methods for predicting therapy efficacy from normalized biomarker scores (2023-12-12),

8. 11705220 - Systems and methods for identifying cancer treatments from normalized biomarker scores (2023-07-18),

9. 11587642 - Systems and methods for deconvolution of expression data (2023-02-21),

10. 11568959 - Tumor microenvironment-based methods for assessing CAR-T and other immunotherapies (2023-01-31),

11. 11482301 - Gene expression analysis techniques using gene rankings and statistical models for identifying biological sample characteristics (2022-10-25),

12. 11430545 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-08-30),

13. 11373733 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-06-28),

14. 11367509 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-06-21),

15. 11322226 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-05-03),

BostonGene Corporation is a biomedical software company focused on revolutionizing personalized medicine through the use of cutting-edge analytics and artificial intelligence. They harness the power of genomics to analyze and interpret large-scale genomic data, providing insights that accelerate the development of targeted therapies and advance disease diagnostics. BostonGene's innovative technology platform enables researchers and clinicians to make data-driven decisions, ultimately improving patient outcomes in oncology and other complex diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

34 Patents

#37 in Waltham, MA

#572 in Massachusetts

#9,670 in US

#19,042 in the World

Waltham, MA, United States of America

Bostongene Corporation

Forward Citations = 133

41 inventors:

Alexander Bagaev (30 out of 30 patents)

Ravshan Ataullakhanov (24 out of 27 patents)

Feliks Frenkel (21 out of 21 patents)

4. Nikita Kotlov (15 out of 15 patents)

5. Olga Isaeva (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…